rs1285847139

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4

The NM_000815.5(GABRD):​c.29C>A​(p.Pro10Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000104 in 960,886 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P10L) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 27)
Exomes 𝑓: 0.0000010 ( 0 hom. )

Consequence

GABRD
NM_000815.5 missense

Scores

2
1
16

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.463

Publications

0 publications found
Variant links:
Genes affected
GABRD (HGNC:4084): (gamma-aminobutyric acid type A receptor subunit delta) Gamma-aminobutyric acid (GABA) is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated chloride channels. Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. The GABA-A receptor is generally pentameric and there are five types of subunits: alpha, beta, gamma, delta, and rho. This gene encodes the delta subunit. Mutations in this gene have been associated with susceptibility to generalized epilepsy with febrile seizures, type 5. Alternatively spliced transcript variants have been described for this gene, but their biological validity has not been determined. [provided by RefSeq, Jul 2008]
GABRD Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics, ClinGen
  • epilepsy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • epilepsy, idiopathic generalized, susceptibility to, 10
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.30481574).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GABRDNM_000815.5 linkc.29C>A p.Pro10Gln missense_variant Exon 1 of 9 ENST00000378585.7 NP_000806.2 O14764A8K496

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GABRDENST00000378585.7 linkc.29C>A p.Pro10Gln missense_variant Exon 1 of 9 1 NM_000815.5 ENSP00000367848.4 O14764

Frequencies

GnomAD3 genomes
Cov.:
27
GnomAD4 exome
AF:
0.00000104
AC:
1
AN:
960886
Hom.:
0
Cov.:
30
AF XY:
0.00000221
AC XY:
1
AN XY:
453146
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
18766
American (AMR)
AF:
0.00
AC:
0
AN:
4688
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
9154
East Asian (EAS)
AF:
0.00
AC:
0
AN:
13496
South Asian (SAS)
AF:
0.0000488
AC:
1
AN:
20488
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
12818
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2270
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
844228
Other (OTH)
AF:
0.00
AC:
0
AN:
34978
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
27

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.056
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
15
DANN
Benign
0.91
DEOGEN2
Benign
0.14
T;.;.;.;.
Eigen
Benign
-0.71
Eigen_PC
Benign
-0.79
FATHMM_MKL
Benign
0.0032
N
LIST_S2
Benign
0.49
T;T;T;T;T
M_CAP
Pathogenic
0.93
D
MetaRNN
Benign
0.30
T;T;T;T;T
MetaSVM
Benign
-0.89
T
MutationAssessor
Benign
0.55
N;.;.;.;.
PhyloP100
-0.46
PrimateAI
Pathogenic
0.85
D
PROVEAN
Benign
-0.99
N;.;.;.;.
REVEL
Benign
0.20
Sift
Uncertain
0.0040
D;.;.;.;.
Sift4G
Benign
0.14
T;.;.;.;.
Polyphen
0.78
P;.;.;.;.
Vest4
0.24
MutPred
0.51
Loss of glycosylation at P10 (P = 0.0598);Loss of glycosylation at P10 (P = 0.0598);Loss of glycosylation at P10 (P = 0.0598);Loss of glycosylation at P10 (P = 0.0598);Loss of glycosylation at P10 (P = 0.0598);
MVP
0.57
MPC
0.70
ClinPred
0.13
T
GERP RS
1.9
PromoterAI
0.042
Neutral
Varity_R
0.079
gMVP
0.53
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1285847139; hg19: chr1-1950891; API